Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RZPD German Resource Center for Genome Research was a leading European provider of genomic resources and services, originally established in 1995 to support the German Human Genome Project. The organization operated as a central repository and service center, offering an extensive collection of cDNA clones, genomic libraries, and high-throughput technologies such as microarrays and DNA sequencing. In 2000, it transitioned from a publicly funded project into a commercial GmbH to better serve the global research community. At its height, RZPD maintained one of the world's largest biobanks of molecular biological materials, including human and model organism clones. The company was acquired in 2007 by the UK-based life sciences group Source BioScience for approximately £1.7 million. This acquisition integrated RZPD's significant technical expertise and vast clone library into Source BioScience's international operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RZPD German Resource Center for Genome Research.